Esophagogastric Junction
Mostrando 1-8 de 8 artigos, teses e dissertações.
-
1. RISK FACTORS FOR SEVERE POSTOPERATIVE COMPLICATIONS AFTER GASTRECTOMY FOR GASTRIC AND ESOPHAGOGASTRIC JUNCTION CANCERS
RESUMO Raciona l: A gastrectomia é o tratamento principal para o câncer de junção esofagogástrica (EGJ) e Siewert tipo II-III. Ela está associada à morbidade significativa. As taxas de morbidade total variam entre os diferentes estudos e poucos avaliaram a morbidade pós-operatória de acordo com a gravidade da complicação. Objetivo: Identificar o
ABCD, arq. bras. cir. dig.. Publicado em: 20/12/2019
-
2. ADJUVANT CHEMORADIOTHERAPY AFTER SUBTOTAL OR TOTAL GASTRECTOMY AND D2 LIMPHADENECTOMY INCREASES SURVIVAL IN ADVANCED GASTRIC CANCER?
RESUMO Racional: O tratamento do câncer gástrico avançado com intenção curativa é essencialmente cirúrgico e a quimiorradioterapia está indicada como neo ou adjuvância para controlar a doença e prolongar a sobrevida. Objetivos: Avaliar a sobrevida dos doentes submetidos à gastrectomia subtotal ou total com linfadenectomia D2 seguidos de quimiorr
ABCD, arq. bras. cir. dig.. Publicado em: 20/12/2019
-
3. As Repercussões da Lesão Medular sobre a Ação da Crura Diafragmática e na Contenção do Refluxo Gastroesofágico: um estudo transversal, não experimental / The repercussions of spinal cord injury on the action of the diaphragmatic crura for gastroesophageal reflux containment
Study design: Cross-sectional and non-experimental. Objective: To detect and compare functional abnormalities in the esophagus and esophagogastric junction in two groups with chronic spinal injuries, one with injuries at the phrenic innervation level and the other at upper thoracic levels, and to relate these to gastroesophageal reflux containment. Summary o
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 30/09/2009
-
4. Dysplasia and adenocarcinoma of the Barrett s esophagus secondadry to the duodenogastroesophagic reflux and sodium nitrite : experimental study in rats / Displasia e adenocarcinoma no esofago de Barrett secundarios ao refluxo duodeno-esofago-gastrico e nitrito de sodio : estudo experimental em ratos
The nitrates and nitrites are salts has been using a lot as conservants and chemical additives of foods, that in this current context of accentuated increase of the world population and shortage of foods, they will be used more. On the other hand, the profile of the society is more and more to use industrialized foods ready for consumption, which they utiliz
Publicado em: 2009
-
5. Antireflux valve self-expanding stent in the treatment of advanced gastroesophageal junction tumors / "Tratamento dos tumores avançados da junção esofagogástrica por prótese auto-expansível com válvula anti-refluxo"
Background: Placement of stents through the gastroesophageal junction can cause reflux. Objective and methods: Evaluate dysphagia palliation, aspiration symptoms, nutritional parameters and quality of life in 30 patients treated for advanced gastroesophageal junction tumors with a self-expanding metal stent with anti-reflux valve from 2001 to 2004. Results:
Publicado em: 2005
-
6. Resection of terminal vagal branches to parietal cell mass in the treatment of duodenal ulcer.
In order to completely denervate the parietal cell mass and to prevent the undesirable side effects of highly selective vagotomy, the authors devised a new and simpler modified operative procedure. First, the anterior and posterior leaves of the lesser omentum are divided from the stomach at their attachment 6 cm proximal to the pylorus to the level 2 to 2.5
-
7. The significance of c-erb B-2 and p53 immunoreactivity in patients with adenocarcinoma of the esophagus.
OBJECTIVE: Studies in breast cancer suggest that p53 and c-erb B2 protein overexpression are predictive of outcome. The authors determined whether these molecular markers correlated with treatment response and survival in patients with adenocarcinoma of the esophagus and esophagogastric junction. METHOD: Immunostaining for p53 and c-erb B2 was performed on p
-
8. Vagotomy, antrectomy, and Roux-en-Y diversion for complex reoperative gastroesophageal reflux disease.
OBJECTIVE: Failure of conventional surgical therapy for treatment of patients with gastroesophageal reflux disease (GERD) taxes the ingenuity of the esophageal surgeon. This study defines the role of vagotomy, antrectomy, and Roux-en-Y diversion coupled, when necessary, with resection of the esophagogastric junction as an alternative to other surgical proced